The Role of Runx2 in Microtubule Acetylation in Bone Metastatic Breast Cancer Cells.
Ontology highlight
ABSTRACT: Bone metastasis of breast cancer results in severe bone loss, fractures, and death. Crosstalk between breast cancer cells and bone resident cells promotes osteoclast activity and the release of growth factors from the bone matrix resulting in aggressive tumor growth and bone loss. We and others have shown that Runt-related transcription factor-2 (Runx2) promotes metastatic tumor growth-associated bone loss. Breast cancer cells also induce autophagy to survive metabolic stress at the metastatic site. Recently, we reported a Runx2-dependent increase in autophagy. In this study, to examine the underlying mechanisms of metastasis and tumor resistance to stress, we used a bone metastatic isogenic variant of breast cancer MDA-MB-231 cells isolated from a xenograft tumor mouse model of metastasis
SUBMITTER: Othman A
PROVIDER: S-EPMC9323014 | biostudies-literature | 2022 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA